| Original language | English (US) |
|---|---|
| Pages (from-to) | 217-222 |
| Number of pages | 6 |
| Journal | Controlled clinical trials |
| Volume | 11 |
| Issue number | 4 |
| DOIs | |
| State | Published - Aug 1990 |
Bibliographical note
Funding Information:Traditionally, the NHLBI has sought to initiate and support trails via a variety of mechanisms. Among the extramural lipid/atherosclerosis trials funded by the NHLBI, the Minnesota Coronary Survey \[5\]t, he Coronary Drug Project (CDP) \[6\]t, he Cholesterol Lowering Atherosclerosis Study (CLAS) \[7\]a, nd the Program on Surgical Control of the Hyperlipidemias (POSCH) \[8\]a, re all examples of investigator-initiated, grant-funded trials. Examples of institute-initiated, contract-funded trials include the Multiple R~sk Factor Intervention TRIAL (MRFIT) \[9\]t,h e Lipid Research Clinics-Coronary Primary Prevention Trial (LRC-CPPT) \[10\]a, nd the Post-Coronary Artery Bypass Graft (Post-CABG) Trial \[11\]T. he recent request for application (RFA) from the NHLBI for a multicenter study of postprandial lipoproteins and atherosclerosis would modify grant funding via a cooperative agreement.